A possible role of miRNAs in the determination of breast cancer stem cells has been suggested through the demonstration of differential expression of miRNAs in CD44+/CD24-/low breast cancer stem cells versus non-tumorigenic cancer cells (145). The gene discussed is CD44; the disease is breast carcinoma.